These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10093863)

  • 1. Placebo-controlled studies in schizophrenia--ethical and scientific perspectives: an overview of conference proceedings.
    Zipursky RB; Darby P
    Schizophr Res; 1999 Feb; 35(3):189-200. PubMed ID: 10093863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary?
    Weijer C
    Schizophr Res; 1999 Feb; 35(3):211-8; discussion 227-36. PubMed ID: 10093865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More on ethics of drug discontinuation studies in schizophrenia.
    Neylan TC; Wright BA; Shelton MD; van Kammen DP
    Arch Gen Psychiatry; 1990 Feb; 47(2):192. PubMed ID: 1967928
    [No Abstract]   [Full Text] [Related]  

  • 4. Placebo-controlled trials in psychiatric research: an ethical perspective.
    Miller FG
    Biol Psychiatry; 2000 Apr; 47(8):707-16. PubMed ID: 10773177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sense and nonsense: an essay on schizophrenia research ethics.
    Carpenter WT; Conley RR
    Schizophr Res; 1999 Feb; 35(3):219-25; discussion 227-36. PubMed ID: 10093866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rationale and ethics of medication-free research in schizophrenia.
    Carpenter WT; Schooler NR; Kane JM
    Arch Gen Psychiatry; 1997 May; 54(5):401-7. PubMed ID: 9152092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues.
    Brabbins C; Butler J; Bentall R
    Br J Psychiatry; 1996 May; 168(5):540-4. PubMed ID: 8733791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The call of the sirens. Navigating the ethics of medication-free research in schizophrenia.
    Fins JJ; Miller FG
    Arch Gen Psychiatry; 1997 May; 54(5):415-6. PubMed ID: 9152094
    [No Abstract]   [Full Text] [Related]  

  • 9. Informed consent in psychiatric research: preliminary findings from an ongoing investigation.
    Benson PR; Roth LH; Winslade WJ
    Soc Sci Med; 1985; 20(12):1331-41. PubMed ID: 2862705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical questions raised by a proposed randomized, double-blind study involving placebo, standard drug therapy, and experimental antipsychotic drug therapy for patients with schizophrenia.
    Abrams RA; Veenhuis P
    Clin Res; 1986 Jan; 34(1):6-9. PubMed ID: 2873917
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: The use of placebos in clinical trials for acute schizophrenia.
    Zipursky RB
    Can J Psychiatry; 1995 Sep; 40(7):425-6. PubMed ID: 8548724
    [No Abstract]   [Full Text] [Related]  

  • 12. Informed consent for psychiatric research: the case of medication-free research.
    Berghmans RL
    Med Law; 1999; 18(4):515-24. PubMed ID: 10687359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective.
    Laughren TP
    Eur Psychiatry; 2001 Nov; 16(7):418-23. PubMed ID: 11728855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research in schizophrenia and the discontinuation of antipsychotic medications.
    Wyatt RJ
    Schizophr Bull; 1997; 23(1):3-9. PubMed ID: 9050108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled trials: when are they needed?
    Streiner DL
    Schizophr Res; 1999 Feb; 35(3):201-10. PubMed ID: 10093864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia.
    DeGrazia D
    Schizophr Res; 2001 Aug; 51(1):77-86. PubMed ID: 11479069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication-free research with schizophrenic patients. A European perspective.
    Henn FA; Lader M
    Arch Gen Psychiatry; 1997 May; 54(5):412-3. PubMed ID: 9152093
    [No Abstract]   [Full Text] [Related]  

  • 19. Obstacles to clinical research and new drug development in schizophrenia.
    Kane JM
    Schizophr Bull; 1991; 17(2):353-6. PubMed ID: 1679256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the treatment of schizophrenia.
    CME Institute of Physicians Postgraduate Press, Inc
    J Clin Psychiatry; 2007 Mar; 68(3):463-78. PubMed ID: 17388719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.